v3.26.1
Stock Option Plan and Stock-Based Compensation (Tables)
6 Months Ended
Jun. 30, 2026
Stock Option Plan And Stock-based Compensation  
Schedule of stock options granted
                                       
    Number of
Options
    Weighted average
exercise price
    Weighted average
remaining
contractual
term (Years)
    Weighted average
fair value
at Grant date
   

Aggregate

Intrinsic Value

 
Options outstanding at January 1, 2026     2,149,550     $ 1.44       8.01     $ 0.91     $ -  
Granted     -     $ -       -     $ -     $ -  
Exercised     -     $ -       -     $ -     $ -  
Forfeited     -     $ -       -     $ -     $ -  
Options outstanding at March 31, 2026     2,149,550     $ 1.44       7.76     $ 0.91     $ -  
Options vested and exercisable at March 31, 2026     1,366,699     $ 1.53                          

 

    Number of
Options
    Weighted average
exercise price
    Weighted average
remaining
contractual
term (Years)
    Weighted average
fair value
at Grant date
    Aggregate
Intrinsic Value
 
Options outstanding at March 31, 2026     2,149,550     $ 1.44       7.76     $ 0.91     $ -  
Granted     2,160,000     $ 0.16       9.79     $ 0.11     $ -  
Exercised     -     $ -       -     $ -     $ -  
Forfeited     (403,332 )   $ 0.79       -     $ 0.52     $ -  
Options outstanding at June 30, 2026     3,906,218     $ 0.80       8.22     $ 0.51     $ -  
Options vested and exercisable at June 30, 2026     1,521,949     $ 1.49                          
Schedule of non-cash stock-based compensation expense
                               
    Three Months Ended
June
 30,
2026
    Six Months Ended
June
 30,
2026
    Three Months Ended
June
 30,
2025
    Six Months Ended
June
 30,
2025
 
Research and development   $ 12     $ 21     $ 7     $ 19  
Sales and marketing     10       19       6       42  
General and administrative     76       153       38       249  
Total non-cash stock compensation   $ 98     $ 193     $ 51     $ 310  
Schedule of assumptions used
               
    June 30,
2026
    June 30,
2025
 
Risk-free interest rate     3.92 %     4.08 %
Expected life of option grants     6 Years       6 Years  
Expected volatility of underlying stock     87.20 %     54.62 %
Dividends assumption     0 %     0 %
Schedule of fair value of stock options
Schedule of fair value of stock options                
    Shares     Weighted Average
Grant Date
Fair Value
 
Outstanding at January 1, 2026     1,061,500     $ 1.25  
Granted     -     $ -  
Vested     (11,500 )   $ 1.33  
Forfeited     -     $ -  
Outstanding at March 31, 2026     1,050,000     $ 1.24  

 

    Shares     Weighted Average
Grant Date
Fair Value
 
Outstanding at March 31, 2026     1,050,000     $ 1.24  
Granted     3,037,386     $ 0.26  
Vested     (1,000,000 )   $ 1.00  
Forfeited     -     $ -  
Outstanding at June 30, 2026     3,087,386     $ 0.35  
Schedule of non-cash stock-based compensation expenses related to restricted stock units
                               
    Three Months ended
June
 30,
2026
   

Six Months ended

June 30,
2026

    Three Months ended
June
 30,
2025
    Six Months ended
June
 30,
2025
 
Research and development   $ -     $ 1     $ 281     $ 383  
Sales and marketing     -       1       141       193  
General and administrative     322       616       281       492  
Total non-cash stock compensation   $ 322     $ 618     $ 703     $ 1,068